Autologous stem cell-derived dopaminergic neuron transplantation product
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous stem cell-derived dopaminergic neuron transplantation product, covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons [Phase 1]